Introduction

Background
Rapid influenza diagnostic tests (RIDTs) that detect influenza viral antigens are often used at the point of care to obtain quick diagnostic test results. While these tests were developed and introduced prior to the emergence of influenza A(H1N1) 2009, clinicians have utilized these tests routinely to identify patients infected with influenza A(H1N1) 2009 and to make treatment decisions for those patients. Although the specificity of RIDTs as compared to real-time RT-PCR has been shown to be high (90-100%), substantial variation in testing sensitivity (17AE8-76AE7%) in detecting influenza A(H1N1) 2009 has been reported. [1] [2] [3] [4] [5] Previous studies have shown that RIDT sensitivity was correlated with increasing viral titer 2, 6, 7 and that higher RIDT sensitivity was found in younger age groups than older groups. 3, 5, 8, 9 However, these studies were conducted either in pediatric patients or with a small sample of older patients.
Objective
The purpose of this study was to evaluate RIDT performance for the detection of influenza A(H1N1) 2009 in patients by age group, and to determine the association of patient age with RIDT performance. 
Study design
Real-time PCR testing
Comparative and statistical analysis
Of the 2078 specimens, 1414 had undergone RIDT at a healthcare facility before being submitted to NHPHL. Forty-one of these specimens were excluded from this study because the internal control failed to amplify, thus signifying inadequate specimen collection or loss of specimen integrity. The remaining 1373 specimens with known RIDT results and valid rRT-PCR results were used to evaluate the performance of RIDT. Analysis and graphics were conducted using R statistical software, version 2.12.1.
10
Confidence intervals for sensitivities were computed using the method of Agresti and Coull. 11 
Results
Overall RIDT sensitivity and specificity
The mean age of patients with RIDT results was 44AE9 years, ranging from 6 to 87 years with a median of 48 years. 
RIDT sensitivity and specificity by patient age
Patients were divided into 10-year age groups, except for patients younger than 2 years of age. This cohort was grouped separately because previous reports 5, 9 indicate that RIDTs performed on children younger than 2 years exhibit higher sensitivity than RIDTs performed on older patients. The resulting eight age groups were <2 years, followed by 2-9, 10-19, 20-29, 30-39, 40-49, 50-59, and 60 years or older. Table 1 shows RIDT sensitivity and specificity by age group. Specificity was high (94AE3-99AE6%) in all groups. Sensitivity of RIDT varied substantially; the highest RIDT sensitivity (85AE7%) was observed in patients younger than two years, while the lowest was observed in the 40-49 years age group (25AE7%, Figure 1 ), followed by 60+ years (34AE8%) and 50-59 years (40AE6%). A Cochran-Armitage test for trend in sensitivity, using the midpoints of the age intervals as scores, was highly significant (P < 0AE001).
Based on the observed results, ages were then collapsed into younger than 2 years, 2-39 years, and over 39 years. Respective sensitivities were 85AE7%, 60AE3%, and 33AE3%.
Logistic regression, using positive RIDT as outcome, indicated that the odds ratio (OR) for a positive RIDT in patients under 2 years of age was 11AE25 (95% confidence interval [CI] = 2AE88-43AE95) compared to those aged 60 and older. Odds ratios for groups younger than 40 were significant or nearly so (Table 2) .
Another logistic regression, with ungrouped ages as covariate, showed that age was significantly negatively associated with a positive RIDT result (P < 0AE001), with each year increase in age reducing the odds of a positive RIDT by 2AE6%. Sensitivity of 50% occurred at 33AE8 years. Results thus indicated a significant decrease in sensitivity with increasing age. Sensitivity and specificity by RIDT manufacturer groups by all the three RIDT kits. Overall sensitivity was 56AE6%, 48AE8%, and 59AE1% for Binax, Xpect, and BD, respectively. In patients younger than 2 years, sensitivity for Binax, Xpect, and BD was 85AE7%, 100%, and 80%, respectively. The sensitivity for Binax, Xpect, and BD was 66AE7%, 64AE7%, and 58AE1% respectively in 2-39 age group; and 33AE3%, 36%, and 46AE2% respectively in the age 40 and older group.
Discussion
This study analyzed respiratory specimens received by NHPHL during the influenza A(H1N1) 2009 pandemic. RIDT performance in different age groups was evaluated, and the association of age with RIDT sensitivity was determined. Figure 1 . Rapid influenza diagnostic test sensitivity by age group. RIDT sensitivity for the detection of A(H1N1) 2009 decreased with age and was unevenly distributed among age groups. The highest RIDT sensitivity was observed in patients younger than 2 years; by comparison, sensitivity was significantly higher than in patients aged 2-39 years, and patients 40 years and older. Age was significantly negatively associated with a positive RIDT result. This is consistent with other studies 5, 9 that found RIDT sensitivity to be significantly higher in infants and children younger than 2 years than in older children. Although higher sensitivity in younger age groups has been observed in several studies, 3, 5, 8, 9 most of the study subjects were children aged 17 years or younger. Our study examined a broad age spectrum of patients and found that a significant decrease in RIDT sensitivity was associated with increasing age. These data demonstrate that RIDT sensitivity is significantly impacted by age of patients. Thus, clinicians should understand the limitation of RIDT 12 and carefully evaluate negative RIDT results, especially for tests performed on older patients.
This study also evaluated the sensitivity and specificity of three RIDT kits including BinaxNOW Ò Influenza A & B (Binax), Remel XpectÔ Flu A & B (Xpect) and BD DirectigenÔ EZ Flu A+B (BD) compared to real-time RT-PCR for the detection of influenza A(H1N1) 2009 based on age group. Specificity was high (92AE2-99AE4%) in all age groups by all RIDTs. RIDT sensitivities were similar within age groups for the three RIDT kits; although sensitivity of the Xpect for younger than two age group appeared to be slightly higher, it was likely due to the small sample size (n = 1) included in this group. However, decreased RIDT sensitivity with increasing age was observed in all the three RIDT kits and is thought to be due to decreased levels of viral shedding in older patients. 12, 13 These data indicate that our finding that RIDT sensitivity decreased with increasing age is independent of RIDT kit.
Overall sensitivity for Xpect (48AE8%) was lower than that of Binax (56AE6%) and BD (59AE1%) kits. However, this difference is likely because of the small number of specimens (n = 1) tested by Xpect from the <2 age group which normally displays the highest RIDT sensitivity. This discrepancy illustrates the importance of utilizing data from similar patient populations when comparing the performance of RIDT kits.
Factors that can impact RIDT performance include specimen type, 7, 14 time of specimen collection after onset of illness, 7 duration of specimen storage, and transportation conditions. We were not able to compare RIDT performance among different specimen types because 98% of the specimens included in this study were NP swabs. Although information regarding the time of specimen collection after illness onset was not available, most specimens are outbreak-related and thought to be collected soon after illness onset. While no information regarding specimen storage or transport prior to RIDT testing was available, it is assumed that all specimens included in this study were tested promptly after specimen collection.
This study demonstrated that RIDT sensitivity is not uniform across age groups. Younger age groups displayed a higher RIDT sensitivity than older groups. Findings from this study may impact a clinician's interpretation of RIDT test results and ultimately have implications in clinical decision-making. Thus, it is important to enhance the RIDT-users' awareness of the limitation of RIDTs. Negative 
